In today’s Pharmaceutical Executive Daily, we cover the emergence of TrumpRx and its implications for direct-to-consumer drug ...
AI transforms pharmaceutical operations by automating workflows, ensuring transparency, and enhancing compliance, driving ...
Eli Lilly and Company announced a definitive agreement to acquire Aderum Biotechnologies and its leading candidate Ixo-vec. 1 ...
PE: Could DTC programs help simplify the drug-pricing system? O’Dell: I’m guessing that the pharmaceutical manufacturers are ...
The DTC model aligns with Most-Favored-Nation pricing, aiming to close the US drug price gap with other high-income countries ...
Lynkuet is the first dual neurokinin receptor antagonist approved for moderate to severe VMS in menopause, offering a hormone-free treatment option. Phase III OASIS trials showed significant ...
GSK announced FDA’s approval of Blenrep in combination with bortezomib and dexamethasone (BVd) for the treatment of adults diagnosed with relapsed or refractory multiple myeloma who received a minimum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback